Form 4: CONMED Corp Treasurer Johonna Pelletier Granted 8,000 Stock Options

Johonna Pelletier, Treasurer and VP, Tax of CONMED Corp, was granted 8,000 stock options on March 1, 2024, according to a Form 4 filing with the SEC.

Summary

• On March 1, 2024, Johonna Marie Pelletier, Treasurer and VP, Tax of CONMED Corp, was granted 8,000 options to purchase common stock at an exercise price of $79.95.
• The options were granted under the company's 2018 Long-Term Incentive Plan and vest in equal amounts over a five-year period.
• A Power of Attorney was executed on January 29, 2024, authorizing Heather L. Cohen, Lindsey F. Brewer, and Thomas Fistek to act on Pelletier's behalf for Section 16 and Rule 144 filings.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management and shareholder interests.

Positives

• The grant of stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

Stock option grants are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in the medical device industry, similar to companies like Stryker (SYK) and Medtronic (MDT).
• The vesting schedule of five years is also a common practice to ensure long-term commitment.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes management to improve company performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates